An intravenous NAD+ session offered as a monitored longevity/recovery service.
An intravenous NAD+ session offered as a monitored longevity/recovery service.
NAD+ is central to cellular metabolism, but IV NAD+ is not an established treatment that reverses ageing. Commercial use focuses on energy, recovery and wellbeing goals.
NAD+ is a coenzyme in redox reactions and a substrate for enzymes such as sirtuins and PARPs. The clinical significance of infusing NAD+ remains under study.
Human evidence for broad anti-ageing, cognitive or performance benefits is limited compared with the strength of the underlying basic biology.
Infusion rate can affect tolerability. Exact product quality, dose and patient suitability should be reviewed.
Book a clinician-led assessment so suitability and the appropriate treatment pathway can be reviewed.
Book assessmentProduct formulation, pack and pricing information are based on the supplied clinic/pharmacy catalogue data. Availability should be confirmed before fulfilment.